Rwwm Lifted Its Coca Cola Co (KO) Stake; Chimerix (CMRX) Shorts Decreased By 3.23%

June 19, 2017 - By Kurt Siggers

Chimerix Incorporated (NASDAQ:CMRX) had a decrease of 3.23% in short interest. CMRX’s SI was 2.05M shares in June as released by FINRA. Its down 3.23% from 2.12 million shares previously. With 397,100 avg volume, 5 days are for Chimerix Incorporated (NASDAQ:CMRX)’s short sellers to cover CMRX’s short positions. The SI to Chimerix Incorporated’s float is 5.21%. About 82,162 shares traded. Chimerix Inc (NASDAQ:CMRX) has risen 3.54% since June 19, 2016 and is uptrending. It has underperformed by 13.16% the S&P500.

Rwwm Inc increased Coca Cola Co (KO) stake by 4.41% reported in 2016Q4 SEC filing. Rwwm Inc acquired 25,815 shares as Coca Cola Co (KO)’s stock rose 6.48%. The Rwwm Inc holds 611,655 shares with $25.36M value, up from 585,840 last quarter. Coca Cola Co now has $193.59B valuation. The stock declined 0.13% or $0.06 reaching $45.25 on the news. About 3.40 million shares traded. The Coca-Cola Co (NYSE:KO) has declined 0.95% since June 19, 2016 and is downtrending. It has underperformed by 17.65% the S&P500.

Chimerix, Inc. is a biotechnology company. The company has market cap of $248.57 million. The Firm is focused on discovering, developing and commercializing medicines that address unmet medical needs. It currently has negative earnings. The Company’s lead compound, brincidofovir, is in development as an oral and intravenous formulation for the prevention and treatment of deoxyribonucleic acid (DNA) viruses, including smallpox, adenoviruses (AdV), and the human herpesviruses.

Investors sentiment decreased to 0.94 in 2016 Q4. Its down 0.11, from 1.05 in 2016Q3. It worsened, as 16 investors sold Chimerix Inc shares while 31 reduced holdings. 12 funds opened positions while 32 raised stakes. 30.20 million shares or 8.41% less from 32.97 million shares in 2016Q3 were reported. Bank Of Montreal Can accumulated 37,852 shares or 0% of the stock. Voya Invest Mgmt Lc holds 0% or 24,677 shares in its portfolio. Federated Pa holds 0% or 173 shares. Barclays Public Ltd Com stated it has 30,806 shares or 0% of all its holdings. Nationwide Fund Advisors reported 33,596 shares or 0% of all its holdings. Leisure Cap Management has invested 0.13% of its portfolio in Chimerix Inc (NASDAQ:CMRX). The New York-based Aisling Capital Ltd Com has invested 0.51% in Chimerix Inc (NASDAQ:CMRX). Tiaa Cref Inv Mngmt Limited Liability Co holds 0% of its portfolio in Chimerix Inc (NASDAQ:CMRX) for 177,185 shares. Citadel Advisors Limited Liability, a Illinois-based fund reported 96,633 shares. Tudor Investment Corp Et Al stated it has 0.01% of its portfolio in Chimerix Inc (NASDAQ:CMRX). 13,474 were reported by Group Inc One Trading Lp. Tekla Cap Mgmt Ltd Liability Company invested in 308,892 shares. Blackrock Fund Advisors accumulated 1.43M shares or 0% of the stock. Susquehanna Int Limited Liability Partnership accumulated 101,418 shares or 0% of the stock. Redmile Gru Limited Liability Corp reported 1.33% of its portfolio in Chimerix Inc (NASDAQ:CMRX).

Since December 27, 2016, it had 0 insider purchases, and 1 insider sale for $464,367 activity. On Tuesday, December 27 the insider MARIO ERNEST sold $464,367.

Among 7 analysts covering Chimerix Inc (NASDAQ:CMRX), 2 have Buy rating, 1 Sell and 4 Hold. Therefore 29% are positive. Chimerix Inc had 16 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was maintained by Brean Capital with “Buy” on Thursday, August 6. On Tuesday, December 29 the stock rating was downgraded by JP Morgan to “Neutral”. On Tuesday, February 23 the stock rating was maintained by FBR Capital with “Mkt Perform”. On Tuesday, February 23 the stock rating was downgraded by Barclays Capital to “Equal-Weight”. The firm has “Mkt Perform” rating given on Monday, December 28 by FBR Capital. Piper Jaffray maintained the shares of CMRX in report on Monday, December 28 with “Overweight” rating. Morgan Stanley downgraded Chimerix Inc (NASDAQ:CMRX) on Monday, October 5 to “Equal-Weight” rating. The firm has “Buy” rating given on Thursday, September 3 by Citigroup. The stock has “Buy” rating by UBS on Thursday, December 17. The stock of Chimerix Inc (NASDAQ:CMRX) earned “Outperform” rating by FBR Capital on Tuesday, August 18.

Since February 10, 2017, it had 0 insider purchases, and 7 selling transactions for $32.72 million activity. 29,282 shares were sold by Perez Beatriz R, worth $1.32M. Another trade for 42,800 shares valued at $1.74M was sold by Eberly Ceree. Another trade for 354,146 shares valued at $15.94M was sold by Finan Irial. $629,700 worth of stock was sold by DOUGLAS J ALEXANDER JR on Tuesday, March 14. 87,800 shares were sold by SMITH BRIAN JOHN, worth $3.81 million on Wednesday, May 10. TUGGLE CLYDE C also sold $8.32 million worth of The Coca-Cola Co (NYSE:KO) on Friday, February 10.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: